ChromaDex Corp.

NAGE

Explore Our Financial Data > Companies > ChromaDex Corp.

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker	NAGE
CIK	0001386570
SIC	2833
Sector	Manufacturing
Industry Category	Pharmaceutical Products
Industry Group	Medicinal Chemicals

Contact

Address	10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
Website	chromadex.com
Phone	310-388-6706
CEO	Robert N. Fried
Employees	120

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement

Revenue	$129.42 million
Pre-Tax Income	$18.19 million
Net Income	$17.38 million
Net Income to Common	$17.38 million
EPS	$0.20

View All

Balance Sheet

Cash	$64.79 million
Assets	$106.41 million
Liabilities	$29.87 million
Common Equity	$76.54 million
Liabilities & Equity	$106.41 million

View All

Cash Flow Statement

Net Income	$17.38 million
Cash From Operating Activities	$13.50 million
Cash From Investing Activities	$-292,000.00
Cash From Financing Activities	$6.92 million
Change in Cash	$20.13 million

View All

Calculations

NOPAT	$15.55 million
EBITDA	$16.85 million
Price to Earnings	$19.72
Price to Book	$4.48
ROE	N/A

View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Promising Penny Stocks To Consider In March 2026

Over the last 7 days, the U.S. market has dropped 1.6%, but it is up 15% over the past year, with earnings expected to grow by 16% annually in the coming years. In such a landscape, identifying stocks with strong financials and growth potential becomes crucial for investors seeking value beyond large-cap companies. Penny stocks—often smaller or newer firms—still offer compelling opportunities when backed by robust fundamentals, and this article highlights several that stand out as promising...

Article Link

March 2026's Promising Penny Stocks To Watch

Over the last 7 days, the market has dropped 1.6%, but it remains up by 15% over the past year, with earnings expected to grow by 16% annually. In such a climate, identifying stocks with solid financial health can be crucial for investors looking for growth opportunities. Penny stocks—often associated with smaller or newer companies—still hold potential when they demonstrate financial strength and long-term promise.

Article Link

Discovering Opportunities: Clean Energy Fuels And 2 Other Promising Penny Stocks

In the last week, the market has stayed flat, but over the past 12 months, it has risen by 16%, with earnings projected to grow annually at a similar rate. In light of these conditions, identifying stocks with solid fundamentals and growth potential is crucial for investors seeking opportunities. Penny stocks may be an outdated term, yet they represent a valuable investment area for those interested in smaller or newer companies that offer affordability and potential upside when backed by...

Article Link

Payoneer Global And 2 Promising Penny Stocks To Watch

In the last week, the market has stayed flat, but it is up 16% over the past year with earnings forecasted to grow by 16% annually. Though the term 'penny stock' might sound like a relic of past trading days, these smaller or newer companies can still present significant opportunities when supported by solid financials. This article explores three penny stocks that combine balance sheet strength with potential for outsized gains, offering investors a chance to uncover hidden value in quality...

Article Link

Aldeyra Therapeutics And 2 More Promising Penny Stocks For Your Watchlist

Over the last 7 days, the U.S. market has dropped 2.3%, though it has risen by 13% over the past year, with earnings expected to grow by 16% per annum in the coming years. In light of these conditions, identifying stocks with strong fundamentals becomes crucial, particularly when exploring opportunities outside mainstream investments. Although "penny stocks" is a somewhat outdated term, it still refers to smaller or less-established companies that can offer significant potential; here we...

Article Link